<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-MedLine.d172">
    <sentence id="DDI-MedLine.d172.s0" text="Clarity and applicability of drug-drug interaction management guidelines: a systematic appraisal by general practitioners and community pharmacists in the Netherlands.&#xd;&#xa;"/>
    <sentence id="DDI-MedLine.d172.s1" text="Despite the availability and daily use of computerized drug-drug interaction surveillance systems, exposure to potentially relevant drug-drug interactions (DDIs) continues. "/>
    <sentence id="DDI-MedLine.d172.s2" text="DDI management guidelines are often inadequate and clear management options are lacking, which attributes to overriding of DDI signals. "/>
    <sentence id="DDI-MedLine.d172.s3" text="Although general criteria for the development and reporting of high-quality clinical practice guidelines have been identified, it appears these have not yet been applied to DDI management guidelines."/>
    <sentence id="DDI-MedLine.d172.s4" text="The aim of the study was to assess the clarity and applicability of guidelines for the management of potentially harmful DDIs. "/>
    <sentence id="DDI-MedLine.d172.s5" text="We selected 13 DDIs that are potentially harmful for patients and frequently occur in community pharmacy practice in the Netherlands. "/>
    <sentence id="DDI-MedLine.d172.s6" text="The clarity and applicability of the management guidelines of these DDIs were appraised using the appropriate two domains - 'Clarity and presentation' and 'Applicability', of the validated Appraisal of Guidelines for Research and Evaluation (AGREE) Instrument. "/>
    <sentence id="DDI-MedLine.d172.s7" text="The appraisal was performed by 12 community pharmacists and 12 general practitioners. "/>
    <sentence id="DDI-MedLine.d172.s8" text="The standardized domain scores and mean item scores for 'Clarity and presentation' and 'Applicability' were compared. "/>
    <sentence id="DDI-MedLine.d172.s9" text="All DDI management guidelines were generally found to score well on 'Clarity and presentation', but poorly with respect to 'Applicability' (standardized domain scores 68.0 vs 26.1%). "/>
    <sentence id="DDI-MedLine.d172.s10" text="Within the domain 'Clarity and presentation', the item 'tools for application' received the lowest scores. "/>
    <sentence id="DDI-MedLine.d172.s11" text="Within the domain 'Applicability', cost implications, organizational barriers and key review criteria were all poorly documented. "/>
    <sentence id="DDI-MedLine.d172.s12" text="All guidelines presented non-directive advice using words such as 'consider' and 'regularly'. "/>
    <sentence id="DDI-MedLine.d172.s13" text="Developers of DDI management guidelines should take the appropriate domains of the AGREE Instrument into consideration in their development processes. "/>
    <sentence id="DDI-MedLine.d172.s14" text="The applicability of DDI management guidelines should be pretested before publishing. "/>
    <sentence id="DDI-MedLine.d172.s15" text="To improve guideline quality, more attention should particularly be paid to the available tools for applications and cost implications."/>
</document>
